HUMA - Humacyte - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

HUMA is currently covered by 7 analysts with an average price target of $10.35. This is a potential upside of $8.75 (546.88%) from yesterday's end of day stock price of $1.6.

Humacyte's activity chart (see below) currently has 19 price targets and 65 ratings on display. The stock rating distribution of HUMA is 95.83% BUY and 4.17% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 26.13% with an average time for these price targets to be met of 136.25 days.

Highest price target for HUMA is $25, Lowest price target is $10, average price target is $13.

Most recent stock forecast was given by JASON KOLBERT from D. BORAL CAPITAL on 11-Aug-2025. First documented stock forecast 20-Jul-2021.

Currently out of the existing stock ratings of HUMA, 46 are a BUY (95.83%), 2 are a HOLD (4.17%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$25

$23.12 (1229.79%)

$25

8 days ago
(11-Aug-2025)

0/14 (0%)

$23.25 (1328.57%)

Buy

$14

$12.12 (644.68%)

3 months 5 days ago
(14-May-2025)

0/13 (0%)

$12.13 (648.66%)

Buy

$15

$13.12 (697.87%)

$15

5 months 7 days ago
(12-Mar-2025)

1/6 (16.67%)

$12.01 (401.67%)

155

Buy

$10

$8.12 (431.91%)

$7.5

10 months 1 days ago
(18-Oct-2024)

2/5 (40%)

$4.97 (98.81%)

270

Buy

$10

$8.12 (431.91%)

$10

10 months 1 days ago
(18-Oct-2024)

1/6 (16.67%)

$4.97 (98.81%)

430

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is HUMA (Humacyte) average time for price targets to be met?

On average it took 136.25 days on average for the stock forecasts to be realized with a an average price target met ratio 26.13

Which analyst has the current highest performing score on HUMA (Humacyte) with a proven track record?

KRISTEN KLUSKA

Which analyst has the current lower performing score on HUMA (Humacyte) with a proven track record?

VERNON BERNARDINO

Which analyst has the most public recommendations on HUMA (Humacyte)?

Kristen Kluska works at CANTOR FITZGERALD and has 2 price targets and 3 ratings on HUMA

Which analyst is the currently most bullish on HUMA (Humacyte)?

Jason Kolbert with highest potential upside - $23.12

Which analyst is the currently most reserved on HUMA (Humacyte)?

Matt O'brien with lowest potential downside - $2.12

Humacyte in the News

Humacyte, Inc. (HUMA) Suffers a Larger Drop Than the General Market: Key Insights

Humacyte, Inc. (HUMA) closed the most recent trading day at $2.40, moving -1.23% from the previous trading session. The stock fell short of the S&P 500, which registered a loss of 0.37% for the day. Elsewhere, the Dow lost 0.74%, while the tech-heavy Nasdaq lost 0.03%. Coming into today, shares of the company had gained...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?